US Patent

US11752103 — Tramadol hydrochloride solution

Method of Use · Assigned to Athena Bioscience LLC · Expires 2040-09-01 · 14y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method of treating pain by administering an analgesic solution containing tramadol or a pharmaceutically acceptable salt thereof.

USPTO Abstract

Disclosed herein is an analgesic solution for the treatment of pain comprising a pain-relieving effective amount of tramadol or a pharmaceutically acceptable salt thereof, a method of treating pain by administering said analgesic solution to a subject in need thereof, a kit that includes containers of the analgesic solution, and a dosing regimen for the analgesic solution.

Drugs covered by this patent

tramadol-hydrochloride (TRAMADOL HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3197`	—	tramadol-hydrochloride

Patent Metadata

Patent number: US11752103
Jurisdiction: US
Classification: Method of Use
Expires: 2040-09-01
Drug substance claim: No
Drug product claim: Yes
Assignee: Athena Bioscience LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.